Huazhuo Jiedu Prescription Treats Ulcerative Colitis by Inhibiting Excessive Mitophagy via PINK1/Parkin Signaling Pathway
|更新时间:2025-05-07
|
Huazhuo Jiedu Prescription Treats Ulcerative Colitis by Inhibiting Excessive Mitophagy via PINK1/Parkin Signaling Pathway
增强出版
“The Huazhuo Jiedu Formula improves intestinal mucosal damage and mitochondrial structure in mice with ulcerative colitis by regulating the PINK1/Parkin pathway.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 11, Pages: 182-189(2025)
ZHANG Haofeng,ZHOU Jinye,LIU Ziwei,et al.Huazhuo Jiedu Prescription Treats Ulcerative Colitis by Inhibiting Excessive Mitophagy via PINK1/Parkin Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(11):182-189.
Effect of Dima Decoction on BNIP3 Protein and mRNA Expressions inIntestinal Epithelial Cells of Ulcerative Colitis Mice
Microscopic Mechanism of Ulcerative Colitis and New Ideas on Medicine Management Based on Theory of Mutual Interference Between Lucidity and Turbidity
Mechanism of Xiezhuo Jiedu Prescription in Treatment of Ulcerative Colitis by Inhibiting Ferroptosis and Alleviating Intestinal Mucosal Injury Based on Nrf2/SLC7A11/GPX4 Signaling Pathway
Metabolomics Reveals Mechanism of Jatrorrhizine in Treating Ulcerative Colitis in Mice
Related Author
ZHANG Haofeng
ZHI Zheng
YANG Qian
LI Bolin
LI Yi-fang
WANG Rui
ZHA An-sheng
WANG Li-na
Related Institution
Hebei Provincial Hospital of Traditional Chinese Medicine
Anhui University of Chinese Medicine
First Affiliated Hospital of Anhui University of Chinese Medicine
The Second Clinical Medical School of Henan University of Chinese Medicine